KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2025 | $75.00 | Underperform → Neutral | BofA Securities |
| 4/14/2025 | $81.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 2/13/2025 | $85.00 → $89.00 | Underweight → Equal Weight | Barclays |
| 1/17/2025 | $91.00 | Peer Perform → Outperform | Wolfe Research |
| 10/7/2024 | $88.00 → $84.00 | Equal Weight → Underweight | Barclays |
| 5/28/2024 | $85.00 → $95.00 | Neutral → Buy | Citigroup |
| 5/24/2024 | $80.00 → $103.00 | Equal Weight → Overweight | Wells Fargo |
| 5/23/2024 | $96.00 | Market Perform → Outperform | BMO Capital Markets |
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
11-K - DuPont de Nemours, Inc. (0001666700) (Filer)
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
SD - DuPont de Nemours, Inc. (0001666700) (Filer)
Mark Blinn announced as director and chairman and Yi Hyon Paik as director WILMINGTON, Del., June 11, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that Mark A. Blinn and Dr. Yi Hyon Paik will become members of the future board of directors (the "Qnity Board") for Qnity Electronics, Inc., the planned, independent Electronics public company created from DuPont's intended spin-off.* Mr. Blinn will become chairman of the Qnity Board effective with the spin-off. Mr. Blinn was chief executive officer, president, and director of Flowserve Corporation until his retirement in
Breakthrough in Semiconductor Lithography Recognized by the American Chemical Society WILMINGTON, Del., June 10, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that 13 of its current and former scientists and engineers have been named 2025 Heroes of Chemistry by the American Chemical Society (ACS) for an innovative program that progressed semiconductor lithography. The award recognizes the collaborative development of embedded barrier layer technology, a transformative advancement in 193 nm immersion lithography that significantly improved chip fabrication processes by
The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations.